Simeprevir (Olysio®)

NICE TA 331. NHSE clinical commissioning policy statement: Treatment of chronic hepatitis C in patients with cirrhosis

  • Traffic Light
    Red
  • BNF
    5.3.3.2
  • Licensed Indicators
    In combination with peginterferon alfa and ribavirin for treating genotypes 1 and 4 chronic hepatitis C
  • Reference
    APC July 14 , May 15, Sep 15
  • Criteria
  • Provisional
    No

Do you want to add this to your CPD record?

Did you find this page helpful?